Advertisement
At a press briefing on Monday, Tedros Adhanom Ghebreyesus said South Africa’s decision to suspend its vaccination campaign using the AstraZeneca vaccine is “a reminder that we need to do everything we can to reduce circulation of the virus with proven public health measures.”
He said there were some important caveats in the study South Africa cited part of the rationale to delay COVID-19 immunisation, noting the study’s small sample size and the fact that it was done mostly in younger, healthier participants.
Tedros also called for manufacturers to be ready to quickly adapt their vaccines so that they would remain effective.